ResApp Health's (ASX:RAP) shares are in pre-open this morning following the ASX granting the company a trading halt.
ResApp requested the halt pending additional clinical study results.
The company is developing smartphone medical applications for the diagnosis and management of respiratory disease.
The halt will remain in place until the opening of trade on Tuesday 10th November 2015, or earlier if an announcement is made to the market.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.